美股A股
StockGist

SNDL Inc.

SNDLNASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada.
$1.42+2.54%
报价 2026-11-06
市值
$346.4M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -36.0%
$1.15$2.21

筛选结果

pipeline · 2026-11-06
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

同行业市值相近 · Drug Manufacturers - Specialty & Generic
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
SNDLSNDL Inc.$346.4M+2.5%–19%–8.8x–
AQSTAquestive Therapeutics, Inc.$453.1M-1.4%+7.4%58.4%–––
EOLSEvolus, Inc.$449.5M+0.1%+11.5%65.6%–––
KMDAKamada Ltd.$417.1M+5.2%–42.3%23.3x10.8x–
EMBCEmbecta Corp.$350.7M-2.2%+4.3%59.9%3.3x5.8x1.8xCheap
ACBAurora Cannabis Inc.$344.5M+1.0%–-5.9%–––
TLRYTilray Brands, Inc.$326.5M+3.9%–30.1%–––
EBSEmergent BioSolutions Inc.$310.7M+3.6%-9.4%49.4%––4.3x
CGCCanopy Growth Corporation$275.6M-3.6%–27.4%–––
同行中位数––+5.8%45.9%13.3x8.3x3.1x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

报告货币 CAD(非美元)
Metric
2026-09-30
Q3 2026
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
RevenueCAD 235.7MCAD 235.8MCAD 195.9MCAD 252.5MCAD 244.2MCAD 244.8MCAD 204.9MCAD 257.7M
Gross Margin19%23.9%27%27.8%26.3%27.6%27.6%26.7%
Operating Margin-1.4%-2.3%-5.7%4.1%-3.8%1.2%-4%-29.5%
Net IncomeCAD -50.3MCAD -7.8MCAD -9.9MCAD 9.4MCAD -13.3MCAD 2.9MCAD -14.7MCAD -67.1M
Diluted EPS-0.21-0.03-0.040.03-0.050.01-0.06-0.26
Operating Cash FlowCAD 18.3MCAD 3.7MCAD 3.5MCAD 25.3MCAD 31.7MCAD 6.1MCAD 7.8MCAD 24.1M

研究材料